Medtronic 2015 Annual Report Download - page 152

Download and view the complete annual report

Please find page 152 of the 2015 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 166

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166

Medtronic plc
Notes to Consolidated Financial Statements (Continued)
Condensed Consolidating Statement of Cash Flows
Fiscal Year Ended April 24, 2015
CIFSA Senior Notes
(in millions)
Parent
Company
Guarantor
(Medtronic
plc)
Subsidiary
Issuer
(CIFSA)
Subsidiary
Guarantors
Subsidiary
Non-
guarantors
Consolidating
Adjustments Total
Operating Activities:
Net cash provided by (used in) operating
activities $ 26 $ (205) $ 1,472 $ 4,709 $ (1,100) $ 4,902
Investing Activities:
Acquisitions, net of cash acquired (9,700) — — (5,184) — (14,884)
Additions to property, plant, and equipment — — (1) (570) — (571)
Purchases of marketable securities — — — (7,582) — (7,582)
Sales and maturities of marketable securities — — — 5,890 — 5,890
Net decrease in intercompany loans — (7,401) (1,303) (18,887) 27,591 —
Other investing activities, net — — — 89 — 89
Net cash used in investing activities (9,700) (7,401) (1,304) (26,244) 27,591 (17,058)
Financing Activities:
Acquisition-related contingent consideration — — — (85) — (85)
Change in short-term borrowings, net — — — (1) — (1)
Repayment of short-term borrowings (maturities
greater than 90 days) — — — (150) — (150)
Proceeds from short-term borrowings (maturities
greater than 90 days) — — — 150 — 150
Issuance of long-term debt — — — 19,942 — 19,942
Payments on long-term debt — (51) — (1,217) — (1,268)
Dividends to shareholders (435) — — (902) — (1,337)
Issuance of ordinary shares 172 — — 477 — 649
Repurchase of ordinary shares (300) — — (1,620) — (1,920)
Net intercompany loan borrowings (repayments) 10,500 8,385 2 8,704 (27,591) —
Intercompany dividend paid — — — (1,100) 1,100 —
Other financing activities — — — (31) — (31)
Net cash provided by financing activities 9,937 8,334 2 24,167 (26,491) 15,949
Effect of exchange rate changes on cash and cash
equivalents — — — (353) — (353)
Net change in cash and cash equivalents 263 728 170 2,279 — 3,440
Cash and cash equivalents at beginning of period — — — 1,403 — 1,403
Cash and cash equivalents at end of period $ 263 $ 728 $ 170 $ 3,682 $ — $ 4,843
142